Literature DB >> 1390331

Choice of ACE inhibitor for congestive heart failure.

L H Opie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1390331     DOI： 10.1007/bf00054568

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  7 in total

1.  Low-dose enalapril in severe chronic heart failure.

Authors:  C G Brilla; B Krämer; H M Hoffmeister; W Müller-Schauenburg; T Risler; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

2.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study.

Authors:  H Pouleur; M F Rousseau; C Oakley; L Rydén
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

5.  Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.

Authors:  P M Schofield; N H Brooks; G P Lawrence; H J Testa; C Ward
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

6.  Comparison of captopril and enalapril in patients with severe chronic heart failure.

Authors:  M Packer; W H Lee; M Yushak; N Medina
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

7.  Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function.

Authors:  K J Osterziel; R Dietz; K Harder; W Kübler
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.